{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:08Z","timestamp":1790483288054,"version":"4.1.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["NL-2018-000171"],"award-info":[{"award-number":["NL-2018-000171"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210179","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T13:38:31Z","timestamp":1547127511000},"page":"e0210179","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-4671","authenticated-orcid":true,"given":"Stephanie","family":"Popping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J.","family":"Hullegie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Boerekamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. A.","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"de Knegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen K.","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A. B.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A. M. C.","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jvh.12611","article-title":"Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study","volume":"24","author":"EB Tapper","year":"2017","journal-title":"J Viral Hepat"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.28625","article-title":"Real-world effectiveness of ledipasvir\/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients","volume":"64","author":"LI Backus","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/cix1007","article-title":"Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy","volume":"66","author":"A Boerekamps","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref4","article-title":"Can HCV direct-acting antiviral treatment as prevention reverse the HCV epidemic amongst men who have sex with men in the UK\u2014epidemiological and modelling insights","author":"NK Martin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref5","unstructured":"Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Geneva: 2017 CC BY-NC-SA 3.0 IGO."},{"key":"ref6","article-title":"Effective but costly: How to tackle difficult tradeoffs in evaluating health improving technologies in liver diseases","author":"LG Mantovani","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12879-016-1807-5","article-title":"Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis","volume":"16","author":"DJ Smith","year":"2016","journal-title":"BMC Infect Dis"},{"key":"ref9","article-title":"HIV monitoring report 2016","author":"A. van Sighem ea","year":"2016","journal-title":"Human Immunodeficiency Virus (HIV) infection in the Netherlands"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"TJ van de Laar","year":"2010","journal-title":"Aids"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/add.12125","article-title":"Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?","volume":"108","author":"AS de Vos","year":"2013","journal-title":"Addiction"},{"issue":"11","key":"ref12","first-page":"1302","article-title":"Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam","volume":"24","author":"BP Grady","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"209 e1","DOI":"10.1016\/j.cmi.2015.10.012","article-title":"Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014","volume":"22","author":"SJ Hullegie","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref14","article-title":"HIV monitoring report 2015. Human Immunodeficiency Virus (HIV) infection in the Netherlands","author":"A Van Sighem","year":"2015"},{"key":"ref15","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe HIV\/AIDS surveillance in Europe 2013, European Centre for Disease Prevention and Control, Stockholm (2014)."},{"key":"ref16","article-title":"Acute Hepatitis C in the Netherlands; characteristics of the epidemic in 2014","author":"SJ Hullegie","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1097\/QAI.0000000000000208","article-title":"Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam","volume":"66","author":"JW Vanhommerig","year":"2014","journal-title":"Jaids-J Acq Imm Def"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2016.09.004","article-title":"HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe","volume":"66","author":"P Ingiliz","year":"2017","journal-title":"J Hepatol"},{"key":"ref19","article-title":"HIV monitoring report 2015. Human Immunodeficiency Virus (HIV) infection in the Netherlands","author":"GL Van Sighem A","year":"2015","journal-title":"Amsterdam HIV monitoring foundation"},{"key":"ref20","article-title":"Monitoring Report 2013, HIV infection in the Netherlands","author":"A Van Sighem","year":"2013","journal-title":"Monitoring Report 2013, HIV infection in the Netherlands"},{"key":"ref21","article-title":"Human Immunodeficiency Virus (HIV) Infection in the Netherlands","author":"LG Ard van Sighem","year":"2014"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2015.12.004","article-title":"Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients","volume":"64","author":"SJ Hullegie","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/QAI.0000000000000208","article-title":"Stabilizing incidence of hepatitis C virus infection among men who have sex with men in Amsterdam","volume":"66","author":"JW Vanhommerig","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"17","key":"ref24","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"FA Lambers","year":"2011","journal-title":"Aids"},{"key":"ref25","article-title":"Monitoring Report 2014","author":"A Sighem","year":"2014"},{"key":"ref26","article-title":"Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men","author":"L Cotte","year":"2018","journal-title":"Liver Int"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAI.0000000000000145","article-title":"Cost-effectiveness of PrEP in HIV\/AIDS control in Zambia: a stochastic league approach","volume":"66","author":"BE Nichols","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1473-3099(16)30311-5","article-title":"Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study","volume":"16","author":"BE Nichols","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1\u20132","key":"ref29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/for.3980100108","article-title":"Parameter sensitivities, monte carlo filtering, and model forecasting under uncertainty","volume":"10","author":"KA Rose","year":"1991","journal-title":"Journal of Forecasting"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"HH Thein","year":"2008","journal-title":"Aids"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","article-title":"Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy","volume":"28","author":"MT May","year":"2014","journal-title":"Aids"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2893.2006.00783.x","article-title":"Comparative study between occult hepatitis C virus infection and chronic hepatitis C","volume":"14","author":"M Pardo","year":"2007","journal-title":"J Viral Hepat"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"EC Thomson","year":"2009","journal-title":"Aids"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"EC Thomson","year":"2011","journal-title":"Gut"},{"issue":"17","key":"ref35","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"FA Lambers","year":"2011","journal-title":"Aids"},{"issue":"16","key":"ref36","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/QAD.0b013e32836381cc","article-title":"Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM","volume":"27","author":"TC Martin","year":"2013","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(15)30202-6","article-title":"LP48: SVR12 results after 12-weeks boceprevir, peginterferon and ribavirin in the dutch acute hepatitis C in HIV study (DAHHs)","volume":"62","author":"SJ Hullegie","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.510250344","article-title":"Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study","volume":"25","author":"S Bruno","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","author":"A Sangiovanni","year":"2004","journal-title":"Gastroenterology"},{"key":"ref40","article-title":"All-oral DAA therapy against HCV in HIV\/HCV-coinfected subjects in real-world practice: Madrid-CoRe Findings","author":"J Berenguer","year":"2018","journal-title":"Hepatology"},{"issue":"27","key":"ref41","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection","volume":"373","author":"JJ Feld","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Electronic address eee. EASL Recommendations on Treatment of Hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol"},{"issue":"27","key":"ref43","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis","volume":"373","author":"MP Curry","year":"2015","journal-title":"N Engl J Med"},{"key":"ref44","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C 2017 ed2017."},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0272989X02238300","article-title":"A meta-analysis of utility estimates for HIV\/AIDS","volume":"22","author":"TO Tengs","year":"2002","journal-title":"Med Decis Making"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cid\/cis382","article-title":"Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men","volume":"55","author":"BP Linas","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref47","first-page":"A528","article-title":"PHS60 Health-Related Quality of Life in HIV\/HCV Co-infected Patients in Ireland Value in Health","volume":"15","author":"A. Mcgreal-bellone SC","year":"2012","journal-title":"PHS60 Health-Related Quality of Life in HIV\/HCV Co-infected Patients in Ireland Value in Health"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S0266462312000062","article-title":"Update of the Dutch Manual for Costing in Economic Evaluations","volume":"28","author":"SS Tan","year":"2012","journal-title":"Int J Technol Assess Health Care"},{"key":"ref49","unstructured":"L.Ryom. EACS guideliness 9.0 2017 2017"},{"key":"ref50","unstructured":"Zorginstituut Nederland\u2014Kosteneffectiviteit in de Praktijk Diemen 2015."},{"key":"ref51","article-title":"Health Economics for Non-economists: An Introduction to the concepts, methods and pitfalls of health economic evaluations","author":"L Annemans","year":"2008"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1524-4733.2010.00736.x","article-title":"Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysis","volume":"13","author":"C Boersma","year":"2010","journal-title":"Value Health"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jval.2012.06.011","article-title":"Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20145","volume":"15","author":"R Pitman","year":"2012","journal-title":"Value Health"},{"key":"ref54","unstructured":"Bruins BJ. Tweede kamer, Geneesmiddelenbeleid 29477. Den Haag 2017\u20132018."},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0000000000001522","article-title":"MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection","volume":"31","author":"E Hoornenborg","year":"2017","journal-title":"AIDS"},{"key":"ref56","article-title":"Stable low hepatitis C virus antibody prevalence among HIV-negative MSM attending the STI outpatient clinic in Amsterdam, 2007\u20132017","author":"AM Newsum","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0956462413515192","article-title":"Limited spread of hepatitis C among HIV-negative men who have sex with men in Stockholm, Sweden","volume":"25","author":"A Blaxhult","year":"2014","journal-title":"Int J STD AIDS"},{"issue":"27","key":"ref58","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMe1513245","article-title":"Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs","volume":"373","author":"JW Ward","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/COH.0000000000000179","article-title":"The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention","volume":"10","author":"NK Martin","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2468-1253(17)30284-4","article-title":"Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe","volume":"3","author":"AD Marshall","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"ofy076","DOI":"10.1093\/ofid\/ofy076","article-title":"Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study","volume":"5","author":"C Gowda","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2016.02.007","article-title":"Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation","volume":"65","author":"NK Martin","year":"2016","journal-title":"J Hepatol"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"e0163488","DOI":"10.1371\/journal.pone.0163488","article-title":"Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands","volume":"11","author":"DK van Santen","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jgh.13223","article-title":"Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia","volume":"31","author":"N Scott","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection","volume":"65","author":"H Midgard","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/hep.28769","article-title":"Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions","volume":"64","author":"L Salazar-Vizcaya","year":"2016","journal-title":"Hepatology"},{"issue":"22","key":"ref67","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection","volume":"376","author":"M Bourliere","year":"2017","journal-title":"N Engl J Med"},{"key":"ref68","article-title":"Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial","author":"X Forns","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref69","article-title":"Internsive hepatitis C monitoring in previously HCV infected HIV-positive MSM is a cost-saving method to reduce the HCV epidemic NCHIV 2016 Amsterdam","author":"S. Popping BEN","year":"2016","journal-title":"Internsive hepatitis C monitoring in previously HCV infected HIV-positive MSM is a cost-saving method to reduce the HCV epidemic NCHIV 2016 Amsterdam"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12916-017-0979-1","article-title":"Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination","volume":"15","author":"V Virlogeux","year":"2017","journal-title":"BMC Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:09:15Z","timestamp":1588997355000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210179"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210179","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734840371.793555069","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]}}}